Biotechnology - Boulder, Colorado, United States
Source MDx is developing and commercializing prognostic, predictive and early detection molecular diagnostic (Precision Profile™) assays and tests for cancer and other inflammatory diseases. Source MDx's patented assays and tests measure RNA-transcript-based gene expression in whole blood using quantitative PCR, optimized for clinical use in a commercial setting.
PHP 5.3
Apache